Heron Therapeutics Inc (NASDAQ:HRTX)

Delayed Data
As of 4:00pm ET
 -0.30 / -1.00%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 40.00, with a high estimate of 56.00 and a low estimate of 33.00. The median estimate represents a +34.91% increase from the last price of 29.65.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 18.21%
Growthannually 30.71%


Growthquarterly 13.12%
Growthannually 107.29%
Key to the earnings and sales forecast charts.